Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Priority to MX9707452ApriorityCriticalpatent/MX9707452A/es
Publication of MXPA97007452ApublicationCriticalpatent/MXPA97007452A/es
Publication of MX9707452ApublicationCriticalpatent/MX9707452A/es
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
Abstract
La espirolaxina y el éter metílico de espirolaxina, los compuestos de las formulas (I) y (II), respectivamente, se pueden mediante la fermentacion de varios hongos. Los hongos que se pueden usar en este procedimiento de fermentacion incluyen Chrysosporium pruinosum UC 8148 ATCC 24782, Chrysosporium pruinosum FD 29454 ATCC 16498, Chrysosporium LN 9913 ATCC 36374, Sporotrichum pruinosum FD 29458 IMI 302923 Y Phanerochaete chrysosporium LN 3576 FPL 11894.
MX9707452A1997-09-291997-09-29Procedimiento para preparar espirolaxina y eter metilico de espirolaxina.
MX9707452A
(es)
Process for producing 4-benzoylisoxazole derivatives, herbicidal compositions containing the compunds as active ingredients and process for using thereof
(r)-3-(n,n-dicyclobutyl-amino)-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxamide hydrogen tartrate, process for its preparation and pharmatceutical compositions of the same